# | Item | Description |
---|---|---|
1 | Review or meta-analysis question | The overall question guiding the review or meta-analysis |
Notes | Use this space to write notes to yourself or other extractors regarding decisions on how to enter data | |
Reported on page # | When used as a reporting tool, indicate the page number where the indicated information can be found | |
ARTICLE CITATION | ||
2 | Study author, publication year | Indicate the study author name and publication year |
3 | Study title | Indicate the study title |
INTRODUCTION | ||
Implementation strategy | “Implementation strategy” refers to how the intervention was implemented. | |
Intervention strategy | “Intervention” refers to the healthcare or public health intervention that is being implemented. | |
4 | Rationale | For implementation strategy: the scientific background and rationale for the implementation strategy (including any underpinning theory/framework/model, how it is expected to achieve its effects and any pilot work). For intervention: the scientific background and rationale for the intervention being implemented (including evidence about its effectiveness and how it is expected to achieve its effects). |
5 | Aim(s), objective(s), or research question(s) | Are there clear aims, objectives, or research questions? Indicate the primary (upon which the study was primarily designed to address) and the secondary (addressing this is prioritized after the primary) |
METHODS: DESCRIPTION | ||
6 | Descriptions | A description of the intervention and implementation strategy. Identify the components that are core components vs those that are tangential and modifiable for the context, if possible. |
7 | Adaptation | A description of any adaptation that has and/or will occur. |
8 | Design | The design and key features of the evaluation, (cross referencing to any appropriate methodology reporting standards) and any changes to study protocol, with reasons |
9 | Participant types | Who are the participants in the intervention and implementation strategy |
10 | Comparison group | If experimental design, indicate the comparison group for the intervention and/or implementation strategy |
11 | Context | The context in which the intervention was implemented. |
12 | Sites | The characteristics of the targeted ‘site(s)’ (e.g locations/personnel/resources etc.) for implementation and any eligibility criteria. |
13 | Subgroups (optional) | Any sub-groups recruited for additional research tasks, and/or nested studies are described |
14 | Implementation phase | Indicate whether evaluation occurred pre-, during , and/or post-implementation |
15 | Process evaluation | Process evaluation objectives and outcomes related to the mechanism by which the strategy is expected to work |
16 | Sample size | Rationale for sample sizes (including sample size calculations, budgetary constraints, practical considerations, data saturation, as appropriate) |
17 | Analysis | Methods of analysis (with reasons for that choice) |
18 | Sub-group analyses | Any a priori sub-group analyses (e.g. between different sites in a multicenter study, different clinical or demographic populations), and sub-groups recruited to specific nested research tasks |
19 | Outcomes (assessment) (Implementation) | Defined pre-specified primary and other outcome(s) of the implementation strategy, and how they were assessed. Document any pre-determined targets |
Quantitative column | Input the specific outcome | |
Qualitative column | Input the specific outcome | |
Acceptability | the perception among implementation stakeholders (beneficiaries and implementers) that the innovation is agreeable, palatable, or satisfactory | |
Adoption | the intention, initial decision, or action to try or employ the innovation (i.e. uptake) | |
Appropriateness | the perceived fit, relevance, or compatibility of the innovation for a given practice setting, provider, or beneficiary; and/or perceived fit of the innovation to address a particular issue or problem (OH prevention). | |
Feasibility | the extent to which the innovation can be successfully used or carried out within a given agency or setting | |
Fidelity | degree to which the innovation can be implemented as it was prescribed in the original protocol or as it was intended by the program developer | |
Cost | (incremental or implementation cost) is defined as the cost impact of an implementation effort | |
Penetration | the integration of a practice within a service setting and its subsystems | |
Sustainability | the extent to which a newly implemented innovation is maintained or institutionalized within a service setting’s ongoing, stable operations | |
19 | Outcomes (assessment) (Intervention) | Defined pre-specified primary and other outcome(s) of the intervention (if assessed), and how they were assessed. Document any pre-determined targets |
Quantitative column | Input the specific outcome | |
Qualitative column | Input the specific outcome | |
Effectiveness | provision of services based on scientific knowledge to all who could benefit and refraining from providing services to those not likely to benefit (avoiding underuse and overuse, respectively) | |
Efficiency | the avoidance of waste, including waste of equipment, supplies, ideas,and energy | |
Equity | provision of care that does not vary in quality because of personalcharacteristics such as gender, ethnicity, geographic location, and socioeconomic status | |
Patient centeredness | provision of care that is respectful of and responsive to individual patient preferences, needs, and values and ensuring that patient values guide all clinical decisions | |
Safety | the avoidance of injuries to patients from the care that is intended to help them | |
Timeliness | reduction of waits and sometimes harmful delays for both thosewho receive and those who give care | |
RESULTS: DESCRIPTION | ||
20 | Outcomes (findings) (Implementation) | Defined pre-specified primary and other outcome(s) of the implementation strategy, and how they were assessed. Document any pre-determined targets |
Quantitative column | Input the specific outcome | |
Qualitative column | Input the specific outcome | |
Acceptability | the perception among implementation stakeholders (beneficiaries and implementers) that the innovation is agreeable, palatable, or satisfactory | |
Adoption | the intention, initial decision, or action to try or employ the innovation (i.e. uptake) | |
Appropriateness | the perceived fit, relevance, or compatibility of the innovation for a given practice setting, provider, or beneficiary; and/or perceived fit of the innovation to address a particular issue or problem (OH prevention). | |
Feasibility | the extent to which the innovation can be successfully used or carried out within a given agency or setting | |
Fidelity | degree to which the innovation can be implemented as it was prescribed in the original protocol or as it was intended by the program developer | |
Cost | (incremental or implementation cost) is defined as the cost impact of an implementation effort | |
Penetration | the integration of a practice within a service setting and its subsystems | |
Sustainability | the extent to which a newly implemented innovation is maintained or institutionalized within a service setting’s ongoing, stable operations | |
20 | Outcomes (findings) (Intervention) | Defined pre-specified primary and other outcome(s) of the intervention (if assessed), and how they were assessed. Document any pre-determined targets |
Quantitative column | Input the specific outcome | |
Qualitative column | Input the specific outcome | |
Effectiveness | provision of services based on scientific knowledge to all who could benefit and refraining from providing services to those not likely to benefit (avoiding underuse and overuse, respectively) | |
Efficiency | the avoidance of waste, including waste of equipment, supplies, ideas,and energy | |
Equity | provision of care that does not vary in quality because of personalcharacteristics such as gender, ethnicity, geographic location, and socioeconomic status | |
Patient centeredness | provision of care that is respectful of and responsive to individual patient preferences, needs, and values and ensuring that patient values guide all clinical decisions | |
Safety | the avoidance of injuries to patients from the care that is intended to help them | |
Timeliness | reduction of waits and sometimes harmful delays for both thosewho receive and those who give care | |
21 | Barriers to implementation | Identify any factors examined that do or could challenge successful implementation |
22 | Facilitators of implementation | Identify any factors examined that do or could support successful implementation |
METHODS: EVALUATION | ||
23 | Design | Follow steps 1, 2, and 3 |
Step 1 | Insert design type: Qualitative, Quantitative RCT, Quantitative non-randomized, or Mixed methods | |
Step 2 | Step 2 insert 5 corresponding criteria from instructions | |
Qualitative criteria | 1.1. Is the qualitative approach appropriate to answer the research question? | |
1.2. Are the qualitative data collection methods adequate to address the research question? | ||
1.3. Are the findings adequately derived from the data? | ||
1.4. Is the interpretation of results sufficiently substantiated by data? | ||
1.5. Is there coherence between qualitative data sources, collection, analysis and interpretation? | ||
Quantitative, RCT criteria | 2.1. Is randomization appropriately performed? | |
2.2. Are the groups comparable at baseline? | ||
2.3. Are there complete outcome data? | ||
2.4. Are outcome assessors blinded to the intervention provided? | ||
2.5 Did the participants adhere to the assigned intervention? | ||
Quantitative, non-randomized criteria | 3.1. Are the participants representative of the target population? | |
3.2. Are measurements appropriate regarding both the outcome and intervention (or exposure)? | ||
3.3. Are there complete outcome data? | ||
3.4. Are the confounders accounted for in the design and analysis? | ||
3.5. During the study period, is the intervention administered (or exposure occurred) as intended? | ||
Mixed methods criteria | 4.1. Is there an adequate rationale for using a mixed methods design to address the research question? | |
4.2. Are the different components of the study effectively integrated to answer the research question? | ||
4.3. Are the outputs of the integration of qualitative and quantitative components adequately interpreted? | ||
4.4. Are divergences and inconsistencies between quantitative and qualitative results adequately addressed? | ||
4.5. Do the different components of the study adhere to the quality criteria of each tradition of the methods involved? | ||
Step 3 | Provide score (0 or 1) to each criteria where 1 indicates that the criteria was met and 0 indicates the criteria was not met | |
RESULTS: EVALUATION | ||
Step 4 | Sum the score from Step 3 and apply to the outcomes assessed | |
24 | Outcomes | |
Bias Column | Indicate the degree of bias based on the design and methods, where 1-2=higher bias and 3-5=lower bias. Can also input 'unclear' if the degree of bias cannot be determined, or 'NA' for outcomes not assessed |